Probiotic supplementation in preterm infants does not affect the risk of bronchopulmonary dysplasia: A meta-analysis of randomized controlled trials

Nutrients

Volumn 9, Issue 11, 2017, Pages

  Villamor Martínez, Eduardo ^a   Pierro, Maria ^b   Cavallaro, Giacomo ^c   Mosca, Fabio ^c   Kramer, Boris ^a   Villamor, Eduardo ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b A MANZONI HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Bronchopulmonary dysplasia; Necrotizing enterocolitis; Probiotics; Sepsis

Indexed keywords

PROBIOTIC AGENT;

ARTIFICIAL VENTILATION; BIFIDOBACTERIUM; BIRTH WEIGHT; CLINICAL OUTCOME; GESTATIONAL AGE; HUMAN; INFANT; LACTOBACILLUS; LUNG DYSPLASIA; META ANALYSIS; MORTALITY; NECROTIZING ENTEROCOLITIS; PREMATURITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; SEPSIS; SUPPLEMENTATION; SYSTEMATIC REVIEW; CHEMICALLY INDUCED; MICROBIOLOGY; NEWBORN; ODDS RATIO; TREATMENT OUTCOME;

BRONCHOPULMONARY DYSPLASIA; ENTEROCOLITIS, NECROTIZING; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; ODDS RATIO; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; SEPSIS; TREATMENT OUTCOME;

EID: 85033465459     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9111197     Document Type: Review

References (85)

1. Farstad, T.; Bratlid, D.; Medbø, S.; Markestad, T.; The Norwegian Extreme Prematurity Study Group. Bronchopulmonary dysplasia—Prevalence, severity and predictive factors in a national cohort of extremely premature infants. Acta Paediatr. 2011, 100, 53-58. [CrossRef] [PubMed]
2. Jobe, A.H.; Bancalari, E. Bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 2001, 163, 1723-1729. [CrossRef] [PubMed]
3. Kramer, B. Antenatal inflammation and lung injury: Prenatal origin of neonatal disease. J. Perinatol. 2008, 28, S21-S27. [CrossRef] [PubMed]
4. Kramer, B.W.; Kallapur, S.; Newnham, J.; Jobe, A.H. Prenatal inflammation and lung development. Semin. Fetal Neonatal Med. 2009, 14, 2-7. [CrossRef] [PubMed]
5. Anderson, P.J.; Doyle, L.W. Neurodevelopmental outcome of bronchopulmonary dysplasia. Semin. Perinatol. 2006, 30, 227-232. [CrossRef] [PubMed]
6. Bhandari, A.; Panitch, H.B. Pulmonary outcomes in bronchopulmonary dysplasia. Semin. Perinatol. 2006, 30, 219-226. [CrossRef] [PubMed]
7. Stoll, B.J.; Hansen, N.I.; Bell, E.F.; Walsh, M.C.; Carlo, W.A.; Shankaran, S.; Laptook, A.R.; Sánchez, P.J.; Van Meurs, K.P.; Wyckoff, M. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 2015, 314, 1039-1051. [CrossRef] [PubMed]
8. Shahzad, T.; Radajewski, S.; Chao, C.-M.; Bellusci, S.; Ehrhardt, H. Pathogenesis of bronchopulmonary dysplasia: When inflammation meets organ development. Mol. Cell Pediatr. 2016, 3, 23. [CrossRef] [PubMed]
9. Speer, C.P. Chorioamnionitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia. Neonatology 2009, 95, 353-361. [CrossRef] [PubMed]
10. Thomas, W.; Speer, C.P. Chorioamnionitis is essential in the evolution of bronchopulmonary dysplasia—The case in favour. Paediatr. Respir. Rev. 2014, 15, 49-52. [CrossRef] [PubMed]
11. Lacaze-Masmonteil, T. That chorioamnionitis is a risk factor for bronchopulmonary dysplasia—The case against. Paediatr. Respir. Rev. 2014, 15, 53-55. [CrossRef] [PubMed]
12. Van Marter, L.J.; Allred, E.N.; Pagano, M.; Sanocka, U.; Parad, R.; Moore, M.; Susser, M.; Paneth, N.; Leviton, A. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? Pediatrics 2000, 105, 1194-1201. [CrossRef] [PubMed]
13. Shah, J.; Jefferies, A.L.; Yoon, E.W.; Lee, S.K.; Shah, P.S. Risk factors and outcomes of late-onset bacterial sepsis in preterm neonates born at <32 weeks’ gestation. Am. J. Perinatol. 2015, 32, 675-682. [PubMed]
14. Hintz, S.R.; Kendrick, D.E.; Stoll, B.J.; Vohr, B.R.; Fanaroff, A.A.; Donovan, E.F.; Poole, W.K.; Blakely, M.L.; Wright, L.; Higgins, R. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics 2005, 115, 696-703. [CrossRef] [PubMed]
15. Pierro, M.; Thébaud, B. Mscs in scenarios of infection and inflammation: Focus on neonatal diseases. Curr. Stem Cell Rep. 2016, 2, 158-167. [CrossRef]
16. Beam, K.S.; Aliaga, S.; Ahlfeld, S.K.; Cohen-Wolkowiez, M.; Smith, P.B.; Laughon, M.M. A systematic review of randomized controlled trials for the prevention of bronchopulmonary dysplasia in infants. J. Perinatol. 2014, 34, 705-710. [CrossRef] [PubMed]
17. Darlow, B.A.; Graham, P. Vitamin a supplementation to prevent mortality and short-and long-term morbidity in very low birth weight infants. Cochrane Database Syst. Rev. 2011, 10, CD000501.
18. Watterberg, K.L. Policy statement—Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia. Pediatrics 2010, 126, 800-808. [CrossRef] [PubMed]
19. Pierro, M.; Ciarmoli, E.; Thébaud, B. Bronchopulmonary dysplasia and chronic lung disease: Stem cell therapy. Clin. Perinatol. 2015, 42, 889-910. [CrossRef] [PubMed]
20. Pierro, M.; Thébaud, B.; Soll, R. Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst. Rev. 2015, CD011932. [CrossRef]
21. Hardy, H.; Harris, J.; Lyon, E.; Beal, J.; Foey, A.D. Probiotics, prebiotics and immunomodulation of gut mucosal defences: Homeostasis and immunopathology. Nutrients 2013, 5, 1869-1912. [CrossRef] [PubMed]
22. Markowiak, P.; Śliżewska, K. Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients 2017, 9, 1021. [CrossRef] [PubMed]
23. AlFaleh, K.; Anabrees, J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst. Rev. 2014, 4, CD005496.
24. Lau, C.S.; Chamberlain, R.S. Probiotic administration can prevent necrotizing enterocolitis in preterm infants: A meta-analysis. J. Pediatr. Surg. 2015, 50, 1405-1412. [CrossRef] [PubMed]
25. Wang, Q.; Dong, J.; Zhu, Y. Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: An updated meta-analysis of 20 randomized, controlled trials. J. Pediatr. Surg. 2012, 47, 241-248. [CrossRef] [PubMed]
26. Aceti, A.; Gori, D.; Barone, G.; Callegari, M.L.; Di Mauro, A.; Fantini, M.P.; Indrio, F.; Maggio, L.; Meneghin, F.; Morelli, L. et al. Probiotics for prevention of necrotizing enterocolitis in preterm infants: Systematic review and meta-analysis. Ital. J. Pediatr. 2015, 41, 89. [CrossRef] [PubMed]
27. Zhang, G.Q.; Hu, H.J.; Liu, C.Y.; Shakya, S.; Li, Z.Y. Probiotics for preventing late-onset sepsis in preterm neonates: A prisma-compliant systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore) 2016, 95, e2581. [CrossRef] [PubMed]
28. Rao, S.C.; Athalye-Jape, G.K.; Deshpande, G.C.; Simmer, K.N.; Patole, S.K. Probiotic supplementation and late-onset sepsis in preterm infants: A meta-analysis. Pediatrics 2016, 137, e20153684. [CrossRef] [PubMed]
29. AlFaleh, K.; Anabrees, J.; Bassler, D. Probiotics reduce the risk of necrotizing enterocolitis in preterm infants: A meta-analysis. Neonatology 2010, 97, 93-99. [CrossRef] [PubMed]
30. Aceti, A.; Gori, D.; Barone, G.; Callegari, M.L.; Fantini, M.P.; Indrio, F.; Maggio, L.; Meneghin, F.; Morelli, L.; Zuccotti, G. Probiotics and time to achieve full enteral feeding in human milk-fed and formula-fed preterm infants: Systematic review and meta-analysis. Nutrients 2016, 8, 471. [CrossRef] [PubMed]
31. Indrio, F.; Riezzo, G.; Tafuri, S.; Ficarella, M.; Carlucci, B.; Bisceglia, M.; Polimeno, L.; Francavilla, R. Probiotic supplementation in preterm: Feeding intolerance and hospital cost. Nutrients 2017, 9, 965. [CrossRef] [PubMed]
32. Klaenhammer, T.R.; Kleerebezem, M.; Kopp, M.V.; Rescigno, M. The impact of probiotics and prebiotics on the immune system. Nat. Rev. Immunol. 2012, 12, 728-734. [CrossRef] [PubMed]
33. Tanaka, K.; Tsukahara, T.; Yanagi, T.; Nakahara, S.; Furukawa, O.; Tsutsui, H.; Koshida, S. Bifidobacterium bifidum olb6378 simultaneously enhances systemic and mucosal humoral immunity in low birth weight infants: A non-randomized study. Nutrients 2017, 9, 195. [CrossRef] [PubMed]
34. Athalye-Jape, G.; Deshpande, G.; Rao, S.; Patole, S. Benefits of probiotics on enteral nutrition in preterm neonates: A systematic review. Am. J. Clin. Nutr. 2014. [CrossRef] [PubMed]
35. Mishra, V.; Shah, C.; Mokashe, N.; Chavan, R.; Yadav, H.; Prajapati, J. Probiotics as potential antioxidants: A systematic review. J. Agric. Food Chem. 2015, 63, 3615-3626. [CrossRef] [PubMed]
36. Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G.; PRIAMA Group. Preferred reporting items for systematic reviews and meta-analyses: The prisma statement. BMJ 2009, 339, b2535. [CrossRef] [PubMed]
37. Agrawal, S.; Rao, S.; Patole, S. Probiotic supplementation for preventing invasive fungal infections in preterm neonates—A systematic review and meta-analysis. Mycoses 2015, 58, 642-651. [CrossRef] [PubMed]
38. Deshpande, G.; Rao, S.; Patole, S.; Bulsara, M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010, 125, 921-930. [CrossRef] [PubMed]
39. Guthmann, F.; Kluthe, C.; Bührer, C. Probiotics for prevention of necrotising enterocolitis: An updated meta-analysis. Klin. Padiatr. 2010, 222, 284-290. [CrossRef] [PubMed]
40. Sawh, S.C.; Deshpande, S.; Jansen, S.; Reynaert, C.J.; Jones, P.M. Prevention of necrotizing enterocolitis with probiotics: A systematic review and meta-analysis. PeerJ 2016, 4, e2429. [CrossRef] [PubMed]
41. Billimoria, Z.C.; Pandya, S.; Bhatt, P.; Pandya, B. Probiotics—To use, or not to use? An updated meta-analysis. Clin. Pediatr. (Phila.) 2016, 55, 1242-1244. [CrossRef] [PubMed]
42. Baucells, B.J.; Hally, M.M.; Sánchez, A.T.Á.; Aloy, J.F. Probiotic associations in the prevention of necrotising enterocolitis and the reduction of late-onset sepsis and neonatal mortality in preterm infants under 1500 g. A systematic review. An. Pediatr. 2016, 85, 247-255. [CrossRef] [PubMed]
43. Olsen, R.; Greisen, G.; Schrøder, M.; Brok, J. Prophylactic probiotics for preterm infants: A systematic review and meta-analysis of observational studies. Neonatology 2016, 109, 105-112. [CrossRef] [PubMed]
44. Cavallaro, G.; Villamor-Martinez, E.; Filippi, L.; Mosca, F.; Villamor, E. Probiotic supplementation in preterm infants does not affect the risk of retinopathy of prematurity: A meta-analysis of randomized controlled trials. Sci. Rep. 2017, 7, 13014. [CrossRef] [PubMed]
45. Higgins, J.P.; Green, S. Cochrane Handbook for Systematic Reviews of Interventions; John Wiley & Sons: Hoboken, NJ, USA, 2011; Volume 4.
46. Borenstein, M.; Hedges, L.V.; Higgins, J.; Rothstein, H.R. Meta-regression. In Introduction to Meta-Analysis; John Wiley & Sons: Chichester, UK, 2009; pp. 187-203.
47. Thompson, S.G.; Higgins, J. How should meta-regression analyses be undertaken and interpreted? Stat. Med. 2002, 21, 1559-1573. [CrossRef] [PubMed]
48. Al-Hosni, M.; Duenas, M.; Hawk, M.; Stewart, L.; Borghese, R.; Cahoon, M.; Atwood, L.; Howard, D.; Ferrelli, K.; Soll, R. Probiotics-supplemented feeding in extremely low-birth-weight infants. J. Perinatol. 2012, 32, 253-259. [CrossRef] [PubMed]
49. Akar, M.; Eras, Z.; Oncel, M.Y.; Arayici, S.; Guzoglu, N.; Canpolat, F.E.; Uras, N.; Oguz, S.S. Impact of oral probiotics on neurodevelopmental outcomes in preterm infants. J. Matern. Fetal Neonatal Med. 2017, 30, 411-415. [CrossRef] [PubMed]
50. Demirel, G.; Erdeve, O.; Celik, I.H.; Dilmen, U. Saccharomyces boulardii for prevention of necrotizing enterocolitis in preterm infants: A randomized, controlled study. Acta Paediatr. 2013, 102, e560-e565. [CrossRef] [PubMed]
51. Dilli, D.; Aydin, B.; Fettah, N.D.; Ozyazici, E.; Beken, S.; Zenciroglu, A.; Okumus, N.; Ozyurt, B.M.; Ipek, M.S.; Akdag, A. et al. The propre-save study: Effects of probiotics and prebiotics alone or combined on necrotizing enterocolitis in very low birth weight infants. J. Pediatr. 2015, 166, 545.e1-551.e1. [CrossRef] [PubMed]
52. Fujii, T.; Ohtsuka, Y.; Lee, T.; Kudo, T.; Shoji, H.; Sato, H.; Nagata, S.; Shimizu, T.; Yamashiro, Y. Bifidobacterium breve enhances transforming growth factor _1 signaling by regulating smad7 expression in preterm infants. J. Pediatr. Gastroenterol. Nutr. 2006, 43, 83-88. [CrossRef] [PubMed]
53. Jacobs, S.E.; Tobin, J.M.; Opie, G.F.; Donath, S.; Tabrizi, S.N.; Pirotta, M.; Morley, C.J.; Garland, S.M.; ProPrems Study Group. Probiotic effects on late-onset sepsis in very preterm infants: A randomized controlled trial. Pediatrics 2013, 132, 1055-1062. [CrossRef] [PubMed]
54. Lin, H.-C.; Hsu, C.-H.; Chen, H.-L.; Chung, M.-Y.; Hsu, J.-F.; Lien, R.-I.; Tsao, L.-Y.; Chen, C.-H.; Su, B.-H. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: A multicenter, randomized, controlled trial. Pediatrics 2008, 122, 693-700. [CrossRef] [PubMed]
55. Manzoni, P.; Rinaldi, M.; Cattani, S.; Pugni, L.; Romeo, M.G.; Messner, H.; Stolfi, I.; Decembrino, L.; Laforgia, N.; Vagnarelli, F. et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: A randomized trial. JAMA 2009, 302, 1421-1428. [CrossRef] [PubMed]
56. Saengtawesin, V.; Tangpolkaiwalsak, R.; Kanjanapattankul, W. Effect of oral probiotics supplementation in the prevention of necrotizing enterocolitis among very low birth weight preterm infants. J. Med. Assoc. Thail. 2014, 97, S20-S25.
57. Sari, F.N.; Eras, Z.; Dizdar, E.A.; Erdeve, O.; Oguz, S.S.; Uras, N.; Dilmen, U. Do oral probiotics affect growth and neurodevelopmental outcomes in very low-birth-weight preterm infants? Am. J. Perinatol. 2012, 29, 579-586. [CrossRef] [PubMed]
58. Serce, O.; Benzer, D.; Gursoy, T.; Karatekin, G.; Ovali, F. Efficacy of saccharomyces boulardii on necrotizing enterocolitis or sepsis in very low birth weight infants: A randomised controlled trial. Early Hum. Dev. 2013, 89, 1033-1036. [CrossRef] [PubMed]
59. Stratiki, Z.; Costalos, C.; Sevastiadou, S.; Kastanidou, O.; Skouroliakou, M.; Giakoumatou, A.; Petrohilou, V. The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants. Early Hum. Dev. 2007, 83, 575-579. [CrossRef] [PubMed]
60. Totsu, S.; Yamasaki, C.; Terahara, M.; Uchiyama, A.; Kusuda, S.; Probiotics Study Group in Japan. Bifidobacterium and enteral feeding in preterm infants: Cluster-randomized trial. Pediatr. Int. 2014, 56, 714-719. [CrossRef] [PubMed]
61. Underwood, M.A.; Salzman, N.H.; Bennett, S.H.; Barman, M.; Mills, D.; Marcobal, A.; Tancredi, D.J.; Bevins, C.L.; Sherman, M.P. A randomized placebo-controlled comparison of two prebiotic/probiotic combinations in preterm infants: Impact on weight gain, intestinal microbiota, and fecal short chain fatty acids. J. Pediatr. Gastroenterol. Nutr. 2009, 48, 216. [CrossRef] [PubMed]
62. Costeloe, K.; Hardy, P.; Juszczak, E.; Wilks, M.; Millar, M.R. Bifidobacterium breve BBG-001 in very preterm infants: A randomised controlled phase 3 trial. Lancet 2016, 387, 649-660. [CrossRef]
63. Long, S.S. Infection and inflammation are associated with long-term morbidities. J. Pediatr. 2017, 180, 1-2. [CrossRef] [PubMed]
64. Been, J.V.; Dieleman, J.P.; Katgert, T.; Boelen-van der Loo, T.; van der Pal, S.M.; van Dijk, M.; Kramer, B.W.; Andriessen, P. Pain coping strategies: Neonatal intensive care unit survivors in adolescence. Early Hum. Dev. 2016, 103, 27-32.
65. Bhandari, V. Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia. Birth Defects Res. Part A Clin. Mol. Teratol. 2014, 100, 189-201. [CrossRef] [PubMed]
66. Payne, N.R.; Barry, J.; Berg, W.; Brasel, D.E.; Hagen, E.A.; Matthews, D.; McCullough, K.; Sanger, K.; Steger, M.D.; Stop Transmission of Pathogens (STOP) team of the St. Paul Campus; et al. Sustained reduction in neonatal nosocomial infections through quality improvement efforts. Pediatrics 2012, 129, e165-e173. [CrossRef] [PubMed]
67. Lapcharoensap, W.; Kan, P.; Powers, R.J.; Shaw, G.M.; Stevenson, D.K.; Gould, J.B.; Wirtschafter, D.D.; Lee, H.C. The relationship of nosocomial infection reduction to changes in neonatal intensive care unit rates of bronchopulmonary dysplasia. J. Pediatr. 2017, 180, 105.e1-109.e1. [CrossRef] [PubMed]
68. Fanaroff, A.A.; Stoll, B.J.; Wright, L.L.; Carlo, W.A.; Ehrenkranz, R.A.; Stark, A.R.; Bauer, C.R.; Donovan, E.F.; Korones, S.B.; Laptook, A.R. Trends in neonatal morbidity and mortality for very low birthweight infants. Am. J. Obstet. Gynecol. 2007, 196, 147.e1-147.e8. [CrossRef] [PubMed]
69. Jobe, A.H.; Bancalari, E.H. Controversies about the definition of bronchopulmonary dysplasia at 50 years. Acta Paediatr. 2017, 106, 692-693. [CrossRef] [PubMed]
70. Poindexter, B.B.; Feng, R.; Schmidt, B.; Aschner, J.L.; Ballard, R.A.; Hamvas, A.; Reynolds, A.M.; Shaw, P.A.; Jobe, A.H. Comparisons and limitations of current definitions of bronchopulmonary dysplasia for the prematurity and respiratory outcomes program. Ann. Am. Thorac. Soc. 2015, 12, 1822-1830. [CrossRef] [PubMed]
71. Passariello, A.; Agricole, P.; Malfertheiner, P. A critical appraisal of probiotics (as drugs or food supplements) in gastrointestinal diseases. Curr. Med. Res. Opin. 2014, 30, 1055-1064. [CrossRef] [PubMed]
72. Mihatsch, W.A.; Braegger, C.P.; Decsi, T.; Kolacek, S.; Lanzinger, H.; Mayer, B.; Moreno, L.A.; Pohlandt, F.; Puntis, J.; Shamir, R. Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants. Clin. Nutr. 2012, 31, 6-15. [CrossRef] [PubMed]
73. Abrahamsson, T.R. Not all probiotic strains prevent necrotising enterocolitis in premature infants. Lancet 2016, 387, 624-625. [CrossRef]
74. Chang, H.-Y.; Chen, J.-H.; Chang, J.-H.; Lin, H.-C.; Lin, C.-Y.; Peng, C.-C. Multiple strains probiotics appear to be the most effective probiotics in the prevention of necrotizing enterocolitis and mortality: An updated meta-analysis. PLoS ONE 2017, 12, e0171579. [CrossRef] [PubMed]
75. Reid, G. Probiotics: Definition, scope and mechanisms of action. Best Pract. Res. Clin. Gastroenterol. 2016, 30, 17-25. [CrossRef] [PubMed]
76. Misra, R.S.; Shah, S.; Fowell, D.J.; Wang, H.; Scheible, K.; Misra, S.K.; Huyck, H.; Wyman, C.P.; Ryan, R.M.; Reynolds, A.M. Preterm cord blood CD4+ T cells exhibit increased il-6 production in chorioamnionitis and decreased cd4+ t cells in bronchopulmonary dysplasia. Hum. Immunol. 2015, 76, 329-338. [CrossRef] [PubMed]
77. Turunen, R.; Vaarala, O.; Nupponen, I.; Kajantie, E.; Siitonen, S.; Lano, A.; Repo, H.; Andersson, S. Activation of T cells in preterm infants with respiratory distress syndrome. Neonatology 2009, 96, 248-258. [CrossRef] [PubMed]
78. Dwivedi, M.; Kumar, P.; Laddha, N.C.; Kemp, E.H. Induction of regulatory t cells: A role for probiotics and prebiotics to suppress autoimmunity. Autoimmun. Rev. 2016, 15, 379-392. [CrossRef] [PubMed]
79. Kwon, H.-K.; Lee, C.-G.; So, J.-S.; Chae, C.-S.; Hwang, J.-S.; Sahoo, A.; Nam, J.H.; Rhee, J.H.; Hwang, K.-C.; Im, S.-H. Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc. Natl. Acad. Sci. USA 2010, 107, 2159-2164. [CrossRef] [PubMed]
80. Cantey, J.B.; Huffman, L.W.; Subramanian, A.; Marshall, A.S.; Ballard, A.R.; Lefevre, C.; Sagar, M.; Pruszynski, J.E.; Mallett, L.H. Antibiotic exposure and risk for death or bronchopulmonary dysplasia in very low birth weight infants. J. Pediatr. 2017, 181, 289.e1-293.e1. [CrossRef] [PubMed]
81. Lohmann, P.; Luna, R.A.; Hollister, E.B.; Devaraj, S.; Mistretta, T.-A.; Welty, S.E.; Versalovic, J. The airway microbiome of intubated premature infants: Characteristics and changes that predict the development of bronchopulmonary dysplasia. Pediatr. Res. 2014, 76, 294-301. [CrossRef] [PubMed]
82. Engelbrektson, A.; Korzenik, J.R.; Pittler, A.; Sanders, M.E.; Klaenhammer, T.R.; Leyer, G.; Kitts, C.L. Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy. J. Med. Microbiol. 2009, 58, 663-670. [CrossRef] [PubMed]
83. Zhang, Q.; Ai, C.; Wang, G.; Liu, X.; Tian, F.; Zhao, J.; Zhang, H.; Chen, Y.; Chen, W. Oral application of lactic acid bacteria following treatment with antibiotics inhibits allergic airway inflammation. J. Appl. Microbiol. 2015, 119, 809-817. [CrossRef] [PubMed]
84. Wemhöner, A.; Ortner, D.; Tschirch, E.; Strasak, A.; Rüdiger, M. Nutrition of preterm infants in relation to bronchopulmonary dysplasia. BMC Pulm. Med. 2011, 11, 7. [CrossRef] [PubMed]
85. Ahmad, A.; Cai, C.L.; Kumar, D.; Cai, F.; D’Souza, A.; Fordjour, L.; Ahmad, T.; Valencia, G.B.; Aranda, J.V.; Beharry, K.D. Benefits of pre-, pro-and syn-biotics for lung angiogenesis in malnutritional rats exposed to intermittent hypoxia. Am. J. Transl. Res. 2014, 6, 459-470. [PubMed]